|
A
Phase III Research Study for Macular Disease (AMD):
Alcon Research, Ltd. is currently conducting a research study in the United Kingdom and other countries. The study aims at evaluating an experimental medicine for the "wet" form of age-related macular degeneration (AMD). General information about AMD is presented here, as well as information about participating in this clinical trial. For more information about participating in this clinical trial, please complete the ONLINE ENQUIRY FORM. We will contact your General Practitioner to find out whether the research study could apply to you.Alcon makes no representations or warranties as to the safety or the effectiveness of this experimental treatment for AMD which you will read about on this web site. Alcon's research study for this treatment must be completed to confirm the safety and efficacy of this experimental treatment and go through Product License approval before it is commercially available.
| ||||
|
||||
 |